IFNG and neoplasm: The investigators generated DEX-SK-BR-3-trimer CD3+ T cells, and revealed that the sensitizing T cells cultured from tumor cells treated with DEX had a stronger ability to secrete IFN-γ compared with non-DEX-treated cells.